Free Trial
TSE:CRON

Cronos Group (CRON) Stock Price, News & Analysis

Cronos Group logo
C$2.86 0.00 (0.00%)
(As of 01:00 PM ET)

About Cronos Group Stock (TSE:CRON)

Key Stats

Today's Range
C$2.86
C$2.92
50-Day Range
C$2.71
C$3.15
52-Week Range
C$2.56
C$4.28
Volume
48,066 shs
Average Volume
155,724 shs
Market Capitalization
C$1.09 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$3.18
Consensus Rating
Hold

Company Overview

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Cronos Group Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
6th Percentile Overall Score

CRON MarketRank™: 

Cronos Group scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cronos Group has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Cronos Group has received no research coverage in the past 90 days.

  • Read more about Cronos Group's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cronos Group is -13.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cronos Group is -13.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Cronos Group has a PEG Ratio of 0.12. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Cronos Group has a P/B Ratio of 1.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CRON.
  • Dividend Yield

    Cronos Group does not currently pay a dividend.

  • Dividend Growth

    Cronos Group does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CRON.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Cronos Group this week, compared to 1 article on an average week.
  • Search Interest

    5 people have searched for CRON on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cronos Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    46.40% of the stock of Cronos Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 15.99% of the stock of Cronos Group is held by institutions.

  • Read more about Cronos Group's insider trading history.
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

3 Penny Stocks On TSX With Market Caps Below CA$2B
Cronos Group (TSE:CRON) Trading Down 2.5% - Here's Why
Pocket $1,100 in 60 Seconds per Day with AI?

What if I told you 60 seconds a day could completely change your life?

My AI-powered trading system finds high-probability option trades in less than 60 seconds a day

See More Headlines

CRON Stock Analysis - Frequently Asked Questions

Cronos Group's stock was trading at C$2.77 at the beginning of the year. Since then, CRON shares have increased by 4.7% and is now trading at C$2.90.
View the best growth stocks for 2024 here
.

Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), NIO (NIO) and Aurora Cannabis (ACB).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
CIK
N/A
Fax
N/A
Employees
450
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$3.18
High Stock Price Target
C$3.54
Low Stock Price Target
C$2.82
Potential Upside/Downside
+11.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
C$-57,370,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$101.78 million
Cash Flow
C$1.71 per share
Book Value
C$2.77 per share

Miscellaneous

Free Float
N/A
Market Cap
C$1.09 billion
Optionable
Not Optionable
Beta
1.02
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (TSE:CRON) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners